Sepulveda v. Saul

CourtDistrict Court, E.D. New York
DecidedMarch 31, 2021
Docket2:19-cv-01123
StatusUnknown

This text of Sepulveda v. Saul (Sepulveda v. Saul) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sepulveda v. Saul, (E.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ------------------------------------------------------------------x CHRISTINE JEAN SEPULVEDA,

Plaintiff, MEMORANDUM AND ORDER - against - 19-CV-1123 (RRM)

ANDREW M. SAUL, Commissioner of Social Security,

Defendant. ------------------------------------------------------------------x ROSLYNN R. MAUSKOPF, United States District Judge.

Christine Jean Sepulveda brings this action against Andrew M. Saul, Commissioner of Social Security (“Commissioner”), seeking review of the Commissioner’s determination that she was not disabled and, therefore, not eligible for Supplemental Security Income (“SSI”) for the period of September 23, 2011, through December 20, 2013. Sepulveda and the Commissioner now cross-move for judgment on the pleadings pursuant to Fed. R. Civ. P. 12(c). (Pl.’s Mem. (Doc. No. 13); Def.’s Mot. (Doc. No. 14).) For the reasons set forth below, the Commissioner’s motion is denied, and Sepulveda’s motion is granted to the extent that it seeks remand. BACKGROUND Sepulveda was born in 1964 and was 49 years old at the end of 2013. Tr. 382.1 She has completed a high school education. Tr. 170. She reported past work as a Bank Manager from October 1984 until August 2011. Tr. 170.

1 Citations preceded by “Tr.” refer to the Administrative Record (Doc. No. 19) and use original pagination. All other page numbers refer to ECF pagination. I. Medical Evidence On April 13, 2011, CT scans of Sepulveda’s chest showed no evidence of pulmonary nodules. Tr. 271. An April 19, 2011 CT scan of the lungs showed no evidence of pulmonary nodules and minimal coronary artery nodules. Tr. 270.

Sepulveda saw her primary care physician, Doctor of Osteopathic medicine (“D.O.”) Dr. Betty Parisis, on November 2, 2011. Tr. 266. Dr. Parisis’s examination revealed that Sepulveda was obese and had gastroesophageal reflux disease (“GERD”), as well as diabetes, extremity pain, depressed mood, anxiety, and paresthesia (a ‘pins and needles’ sensation). Tr. 266. Dr. Parisis noted that Sepulveda should take the following medications: Lantus, an injectable insulin; Victoza, an injectable non-insulin diabetes medication; lisinopril, a high blood pressure medication; Lexapro, an antidepressant; Prevacid, a treatment for GERD; Naproxen, a nonsteroidal anti-inflammatory drug (“NSAID”); Advil or Tylenol; Claritin D, an allergy medicine; fish oil; B12 supplements; iron supplements; calcium and Vitamin D supplements; glucosamine and chondroitin supplements for arthritis; and a multivitamin. Tr. 267.

That same day, Sepulveda saw Dr. Rajeev Vohra, a bariatric surgeon to whom she was referred by Dr. Parisis, for lap band adjustment following a July 2010, lap band surgery; Sepulveda also saw Dr. Vohra a week later on November 9, 2011. Tr. 195–200. For both visits, physical examination of Sepulveda was unremarkable. Tr. 196, 198. Dr. Vohra’s review of Sepulveda’s symptoms noted obesity, diabetes, heartburn, parathesia, and extremity pain and he diagnosed a history of breast cancer, obesity, and paresthesia of the lower extremities. Tr. 196– 99. On November 9, 2011, Sepulveda underwent blood glucose testing, which showed that her blood sugar was in range. Tr. 201. Her creatinine, cholesterol, Vitamin D, and hemoglobin were all out of range. Tr. 201–207. On January 12, 2012, Dr. Parisis prescribed Sepulveda Cymbalta to treat her diabetic peripheral neuropathy. Tr. 262. On February 15, 2012, Dr. Parisis noted that Sepulveda needed to lose weight and that she did not tolerate Cymbalta. Tr. 253. On March 28, 2012, Sepulveda saw Dr. Ellen Braunstein, a neurologist, who was also

referred by Dr. Parisis. Tr. 320–21, repeated at 336–37. Sepulveda reported that she was taking the following medications: Lantus, an injectable insulin; Victoza, an injectable non-insulin diabetes medication; lisinopril, a high blood pressure medication; Crestor, a cholesterol medication; Lexapro, an SSRI; Prevacid, a treatment for GERD; Naprosyn, a nonsteroidal anti- inflammatory drug (“NSAID”); and a multivitamin. Tr. 320. She had also recently started taking Metanx, a Vitamin B supplement used for peripheral neuropathy, which she thought had improved her tingling and numbness in her hands. Tr. 320. Dr. Braunstein noted that Sepulveda had a history of neck pain, carpal tunnel syndrome, peripheral neuropathy, diabetes, and lumbar radiculopathy. Tr. 320–21. On physical examination, Sepulveda appeared comfortable and a mental status

examination showed that she was awake, alert, and fully oriented. Tr. 320. Her memory testing performance was adequate and she could read, write, and copy without difficulty. Tr. 320. On cranial nerve testing, Dr. Braunstein could not visualize Sepulveda’s optic discs, but found her extra ocular movements were intact, and her pupils were equal and reactive to light. Tr. 320. Dr. Braunstein also observed brisk corneal reflexes bilaterally, a symmetrical face, and a bilateral upgoing palate and midline tongue. Tr. 320. Sepulveda had some movement restrictions in her neck, decreased sensation in her third and fourth fingers on both hands, and decreased sensation her lower legs. Tr. 320–21. Dr. Braunstein noted that otherwise she is “diffusely 5/5,” as in full strength, with normal bulk and tone. Tr. 320–21. Sepulveda’s reflexes were noted as “trace, toes downgoing,” and her coordination was consistent with her strength. Tr. 321. Her gait and balance were normal, though she had some difficulty with heel-to-toe walking. Tr. 321. Dr. Braunstein indicated that based on Sepulveda’s history and exam, it appeared that she did have an underlying peripheral neuropathy. Tr. 321. She also had symptoms consistent with lumbar

radiculopathy, she was an insulin dependent diabetic, and she had a history of breast cancer. Tr. 321. Dr. Braunstein recommended that Sepulveda undergo a cervical MRI, nerve conduction testing to assess peripheral nerve function, and electromyographies (“EMGs”) of upper and lower extremities to assess neuromuscular function. Tr. 321. Dr. Braunstein informed Dr. Parisis of this assessment and these tests. Tr. 321. A March 28, 2012 electrodiagnostic study, performed by Dr. Braunstein, was abnormal. Tr. 213, repeated at 311, 327. Nerve conduction studies done on April 2 and 3, 2012, showed diffuse sensory motor neuropathy and abnormal results consistent with bilateral carpal tunnel syndrome. Tr. 210–12, repeated at Tr. 318–19, 326–27, 334–35. Sepulveda saw Dr. Parisis on May 1, 2012, and reported hand numbness. Tr. 251. She

was also diagnosed with neck and back pain, paresthesia, obesity, high blood pressure, high cholesterol, anxiety, and insomnia. Tr. 251. Physical examination indicated obesity and edema. Tr. 250. Dr. Parisis counseled Sepulvada regarding diet and exercise and again urged her to lose weight. Tr. 250. Sepulveda returned to Dr. Braunstein on May 4, 2012, and her physical examination was essentially unchanged from her prior visit. Tr. 208. The nerve conduction studies Dr. Braunstein had performed revealed carpal tunnel syndrome. Tr. 208. Upon a “mini-mental status exam,” Dr. Braunstein found Sepulveda to by awake, alert, and fully oriented. Tr. 208. She was able to repeat three unrelated words and recall them in five minutes, spell forwards and backwards, repeat phrases, and read without difficulty. Tr. 208. Dr. Braunstein stated that Sepulveda should continue on her current treatment regimen and should consider seeing an orthopedist for her carpal tunnel syndrome. Tr. 209. A sonogram taken on May 11, 2012, showed a single, subcentimeter nodule in each lobe

of the thyroid gland. Tr. 215, repeated at Tr. 272. Sepulveda saw an ophthalmologist, Dr. Todd J. Bragin, a few days later on May 14, 2012, for a diabetic eye examination. Tr. 216. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burgess v. Astrue
537 F.3d 117 (Second Circuit, 2008)
Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Petrie v. Astrue
412 F. App'x 401 (Second Circuit, 2011)
Talavera v. Comm’r of Social Security
697 F.3d 145 (Second Circuit, 2012)
Selian v. Astrue
708 F.3d 409 (Second Circuit, 2013)
Cichocki v. Astrue
729 F.3d 172 (Second Circuit, 2013)
Lamay v. Commissioner of Social SEC.
562 F.3d 503 (Second Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Sepulveda v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sepulveda-v-saul-nyed-2021.